Impact of human immunodeficiency virus type 1 (HIV-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIV Network for Prevention Trials 012 study)

Journal of Infectious Diseases

Volumn 184, Issue 7, 2001, Pages 914-917

  Eshleman, Susan H ^a   Becker Pergola, Graziella ^a   Deseyve, Martin ^a   Guay, Laura A ^a   Mracna, Martin ^a   Fleming, Thomas ^a,b   Cunningham, Shawn ^a   Musoke, Philippa ^c   Mmiro, Francis ^c   Jackson, J Brooks ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

NEVIRAPINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UGANDA; VERTICAL TRANSMISSION; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; DISEASE TRANSMISSION, VERTICAL; DRUG RESISTANCE, MICROBIAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; NEVIRAPINE; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UGANDA;

EID: 0035479290     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/323153     Document Type: Article

References (14)

1. A molecular epidemiologic survey of HIV in Uganda
2. Predominance of HIV-1 subtype A and D infections in Uganda
3. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-infant transmission of HIV-1 in Kampala, Uganda: HIVNET-012 randomised trial
4. The one year safety and efficacy data of the HIVNET 012 trial [LbOr1]
5. Selection and fading of resistance mutations in Ugandan women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
6. TreeView: An application to display phylogenetic trees on personal computers
7. Analysis of HIV-1 protease and reverse transcriptase in antiretroviral drug naïve Ugandan adults
8. Identification of diverse HIV-1 subtypes and dual HIV-1 infection in pregnant Ugandan women
9. Dual transmission of subtype A and D HIV-1 viruses from a Ugandan woman to her infant
10. Human immunodeficiency virus type 1 subtypes differ in disease progression
11. Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D
12. Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort
13. Effect of human immunodeficiency virus (HIV) type 1 viral genotype on mother-to-child transmission of HIV-1